Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Lindsay Lee-Waters - Wikipedia

   en.wikipedia.org/wiki/Lindsay_Lee-Waters

   US Open. 2R (1996) Lindsay Lee-Waters (born June 28, 1977) is an American former professional tennis player. Lee-Waters has a career-high WTA singles ranking of No. 33, achieved on 1 April 1996. She also has a career-high WTA doubles ranking of 85, achieved on 25 February 2013. Lee-Waters won eleven singles and 21 doubles titles on the ITF ...

3. Cincinnati Open - Wikipedia

   en.wikipedia.org/wiki/Cincinnati_Open

   The Cincinnati Open (also known as the Cincinnati Masters) is an annual professional tennis event held in Cincinnati, United States.Due to previous sponsorship, it has also been known as: the Thriftway ATP Championships, the Great American Insurance ATP Championships, the Western & Southern Financial Group Masters and Women's Open and, most recently, the Western & Southern Open.

4. Lily Miyazaki - Wikipedia

   en.wikipedia.org/wiki/Lily_Miyazaki

   2R ( 2024) Last updated on: 15 July 2024. Yuriko Lily Miyazaki (born 11 November 1995) is a Japanese-born British tennis player. She has career-high rankings by the WTA of world No. 132 in singles and No. 184 in doubles. [ 2] She has won seven singles titles and eight doubles titles on the ITF Women's Circuit .

5. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

6. Conservationists try to protect ecologically rich Alabama ...

   www.aol.com/news/conservationists-try-protect...

   MOBILE-TENSAW DELTA, Ala. (AP) — Thousands of American lotuses carpet the water's surface, faces turned toward the morning sun. The Mobile-Tensaw Delta — a lush, vibrant and surprisingly ...

7. Twice-yearly shot proves successful at preventing HIV ... - AOL

   www.aol.com/twice-yearly-shot-proves-successful...

   The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and published ...